Literature DB >> 17101902

Clinical and radiographic features of peritumoral infarction following resection of glioblastoma.

S Ulmer1, T A Braga, F G Barker, M H Lev, R G Gonzalez, J W Henson.   

Abstract

Focal areas of restricted diffusion adjacent to high-grade glioma resection cavities were detected in 70% of patients on immediate postoperative MRI studies. Follow-up studies demonstrated cystic encephalomalacia in 91% of these foci, suggesting the presence of infarction, and the infarcted tissue demonstrated enhancement in 43% of cases. New postoperative deficits correlated well with the anatomic region of infarction in six patients. Enhancement in perioperative infarcts can mimic tumor progression on follow-up imaging studies.

Entities:  

Mesh:

Year:  2006        PMID: 17101902     DOI: 10.1212/01.wnl.0000242894.21705.3c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

1.  Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria.

Authors:  Alexander Radbruch; Kira Lutz; Benedikt Wiestler; Philipp Bäumer; Sabine Heiland; Wolfgang Wick; Martin Bendszus
Journal:  Neuro Oncol       Date:  2011-12-06       Impact factor: 12.300

2.  Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma.

Authors:  Stephan Ulmer; Klara Spalek; Arya Nabavi; Susan Schultka; H Maximillian Mehdorn; Santosh Kesari; Lutz Dörner
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

3.  MRI and thallium-201 SPECT in the prediction of survival in glioma.

Authors:  Maaike J Vos; Johannes Berkhof; Otto S Hoekstra; Ingeborg Bosma; Eefje M Sizoo; Jan J Heimans; Jaap C Reijneveld; Esther Sanchez; Frank J Lagerwaard; Jan Buter; David P Noske; Tjeerd J Postma
Journal:  Neuroradiology       Date:  2011-07-14       Impact factor: 2.804

Review 4.  Brain tumor imaging in clinical trials.

Authors:  J W Henson; S Ulmer; G J Harris
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

5.  Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Authors:  Andrea Pirzkall; Colleen McGue; Suja Saraswathy; Soonmee Cha; Raymond Liu; Scott Vandenberg; Kathleen R Lamborn; Mitchel S Berger; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

Review 6.  Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.

Authors:  L C Hygino da Cruz; I Rodriguez; R C Domingues; E L Gasparetto; A G Sorensen
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-10       Impact factor: 3.825

7.  Pseudo progression identification of glioblastoma with dictionary learning.

Authors:  Jian Zhang; Hengyong Yu; Xiaohua Qian; Keqin Liu; Hua Tan; Tielin Yang; Maode Wang; King Chuen Li; Michael D Chan; Waldemar Debinski; Anna Paulsson; Ge Wang; Xiaobo Zhou
Journal:  Comput Biol Med       Date:  2016-04-01       Impact factor: 4.589

8.  Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).

Authors:  Patrick Y Wen; Timothy F Cloughesy; Benjamin M Ellingson; David A Reardon; Howard A Fine; Lauren Abrey; Karla Ballman; Martin Bendszuz; Jan Buckner; Susan M Chang; Michael D Prados; Whitney B Pope; Alma Gregory Sorensen; Martin van den Bent; Wai-Kwan Alfred Yung
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

9.  Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI.

Authors:  Moran Artzi; Gilad Liberman; Guy Nadav; Deborah T Blumenthal; Felix Bokstein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2016-01-11       Impact factor: 4.130

10.  Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value.

Authors:  R-E Yoo; S H Choi; T M Kim; S-H Lee; C-K Park; S-H Park; I H Kim; T J Yun; J-H Kim; C H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.